<?xml version="1.0" encoding="UTF-8"?>
<record
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd"
    xmlns="http://www.loc.gov/MARC21/slim">

  <leader>04983nab a2200361 a 4500</leader>
  <controlfield tag="003">AR-ReUNN</controlfield>
  <controlfield tag="005">20260702002303.0</controlfield>
  <controlfield tag="008">260630s2007    ag |||||||||||||||||spa  </controlfield>
  <datafield tag="100" ind1="1" ind2=" ">
    <subfield code="a">Brem, Juan Jos&#xE9;</subfield>
    <subfield code="9">122206</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
    <subfield code="a">Trulls, Horacio Eduardo</subfield>
    <subfield code="9">122207</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
    <subfield code="a">Picot, Jos&#xE9; Augusto</subfield>
    <subfield code="9">122087</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
    <subfield code="a">Ort&#xED;z de Rus, M. I.</subfield>
    <subfield code="9">125723</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
    <subfield code="a">Lorente, Jos&#xE9; a.</subfield>
    <subfield code="9">125802</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
    <subfield code="a">Ortega, Hugo H&#xE9;ctor</subfield>
    <subfield code="9">125593</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
    <subfield code="a">Brem, Juan Jos&#xE9;</subfield>
    <subfield code="9">122206</subfield>
  </datafield>
  <datafield tag="245" ind1="1" ind2="0">
    <subfield code="a">Respuesta del tejido trabecular &#xF3;seo y la concentraci&#xF3;n de minerales a la terapia hormonal de reemplazo en ratas ovariectomizadas / J. J. Brem ... [et al.]</subfield>
  </datafield>
  <datafield tag="264" ind1=" " ind2="1">
    <subfield code="c">2007</subfield>
  </datafield>
  <datafield tag="300" ind1=" " ind2=" ">
    <subfield code="a">5 p&#xE1;ginas</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">Resumen:  La ausencia o disminuci&#xF3;n de estr&#xF3;genos y progesterona causan p&#xE9;rdida de masa &#xF3;sea. En la osteoporosis posmenop&#xE1;usica aumenta la fragilidad esquel&#xE9;tica por disminuci&#xF3;n de la resistencia biomec&#xE1;nica del hueso frente al desaf&#xED;o de cargas deformantes de escasa intensidad, situaci&#xF3;n que en la mujer exige terapia hormonal. El objetivo del presente estudio fue determinar los efectos de la terapia con estr&#xF3;genos y progesterona sobre el tejido trabecular tibial de ratas ovariectomizadas, as&#xED; como registrar en sangre y huesos el comportamiento de analitos relacionados al metabolismo &#xF3;seo. Se usaron 45 ratas Wistar de 4 meses de edad, agrupadas en lotes castrado (n = 24) y control (n = 21). El ensayo dur&#xF3; 19 meses. Seis meses antes de finalizar, la mitad de los animales ovariectomizados recibieron 5 dosis mensuales de 250 ug de benzoato de estradiol y 6,25 mg de caproato de hidroxiprogesterona via SC. A los 30 d&#xED;as de culminado el tratamiento las ratas fueron sacrificadas, extray&#xE9;ndose muestras de sangre y hueso. La histomorfometr&#xED;a mostr&#xF3; una buena recuperaci&#xF3;n del espesor trabecular en la met&#xE1;fisis tibial de los animales tratados con hormonas, cuyos par&#xE1;metros resultaron similares a los testigos (43,47 &#xB1; 2,87 y 43,09 &#xB1; 7,49 um respectivamente). En cambio, en el resto de los animales castrados el espesor trabecular permaneci&#xF3; disminuido (30,93 &#xB1; 5,25 um, p &lt; 0,05). El contenido mineral del hueso no registr&#xF3; variaciones significativas entre lotes, pero en sangre se verificaron disminuciones significativas de magnesio en ambos lotes castrados, as&#xED; como de fosfatasa alcalina en los tratados hormonalmente. Se concluye que a pesar del tratamiento tard&#xED;o realizado, se logr&#xF3; mantener el espesor de las trab&#xE9;culas &#xF3;seas del tejido esponjoso tibial en ratas ovariectomizadas.  Abstract:  Lack or decrease of estrogen and progesterone production may lead to loss of osseous tissue. Skeletal fragility  increases in postmenopausal osteoporosis because the bone biomechanic resistance decrease, this being evident when it is submitted to deforming loads of scarce intensity; the latter condition in postmenopausal woman makes hormonal replacement therapy necessary. The aim of this study was to determine the effects of a therapy based on estrogen and progesterone administration, on tibial spongiose tissue in ovariectomized rats, as well as to observe the behavior of blood and osseous analytes related to bone metabolism. Female Wistar rats, 4 months-old, were used. They were divided into lots of 24 castrated animals and 21 non-castrated controls. The test last 19 months. Six months before the end of the experiment, half of the ovariectomized rats received five SC doses of 250 ug benzoate of estradiol and 6.25 mg of caproate of hydroxyprogesterone, once a month. Thirty days after the end of treatments, rats were euthanized, and blood and osseosus tissue samples were taken for laboratory studies. Histomorphometry revealed a good recuperation of spongiose density at tibial metaphysis from castrated animals, which received the hormonal treatment; data were similar in controls (43.47 &#xB1; 2.87 um and 43.09 &#xB1; 7.49 um, respectively). On the contrary, an important decrease of density was observed in castrated females without treatment (30.93 &#xB1; 5.25 um, p &lt; 0.05). Blood analyses showed a significant decrease for magnesium in both castrated lots, regarding to controls, and alkaline phosphatase only in those castrated that received hormonal treatment. The chemical analyses performed on bone tissue did not show mineral parameter differences among lots. In conclusion, despite the estrogen-progesterone treatment performed lately, maintenance of cancellous bone density from tibial spongiose tissue in ovariectomized rats was achieve.</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="4">
    <subfield code="a">Rata</subfield>
    <subfield code="9">117553</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="4">
    <subfield code="a">Ovariectomia</subfield>
    <subfield code="9">118190</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="4">
    <subfield code="a">Osteoporosis</subfield>
    <subfield code="9">119680</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="4">
    <subfield code="a">Sistema Oseomuscular</subfield>
    <subfield code="9">117606</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="4">
    <subfield code="a">Minerales</subfield>
    <subfield code="9">9621</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="4">
    <subfield code="a">Estrogenos</subfield>
    <subfield code="9">118176</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="4">
    <subfield code="a">Progesterona</subfield>
    <subfield code="9">118177</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="4">
    <subfield code="a">Tratamiento Hormonal</subfield>
    <subfield code="9">125803</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="4">
    <subfield code="a">Aparato Locomotor</subfield>
    <subfield code="9">117608</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
    <subfield code="t">Revista Veterinaria</subfield>
    <subfield code="x">1668-4834</subfield>
    <subfield code="g">v. 16 n. 2 (2005)</subfield>
    <subfield code="w">217547</subfield>
  </datafield>
  <datafield tag="942" ind1=" " ind2=" ">
    <subfield code="c">ART</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
    <subfield code="a">(AGROP)41097</subfield>
  </datafield>
  <controlfield tag="001">217726</controlfield>
  <datafield tag="999" ind1=" " ind2=" ">
    <subfield code="c">217726</subfield>
    <subfield code="d">217726</subfield>
  </datafield>
  <datafield tag="040" ind1=" " ind2=" ">
    <subfield code="a">AR-ReUNN</subfield>
    <subfield code="b">spa</subfield>
    <subfield code="c">AR-ReUNN</subfield>
    <subfield code="e">aacr2</subfield>
  </datafield>
</record>
